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Abstract 
Namibia has a small population of about 2 million people and  its HIV/AIDS situation is not 
different from that of the global trend. Approximately 20% of the sexually active adult 
population lives with the virus (MoHSS, 2008). Studies carried out in Namibia in 2008 shows 
that 6o% of the female were infected with HIV meaning the other 40% accounted for the rest of 
the population involving  men and children (MoHSS,2008). This became a cause for concern to 
stimulate a research in this category of subjects. In Namibia, the national sentinel  prevalence 
was 18.8% among HIV pregnant women between  ages 15- 49years. And Oshakati was the third 
highest HIV/AIDS prevalence district in the country with 25.1% and this is higher than the 
national average.(MoHSS, 2010:12).This stimulated interest for this study in Oshakati district in 
Namibia. 
 
Study objective of the Research: The objective was to establish the reason for poor adherence 
amongst female-HIV/AIDS patients, 15-24 years of age, currently taking their medications from 
Oshakati Hospital‟s ARV Clinic in order to recommend good guidelines that will help to 
improve adherence practices. 
 
Methods: A quantitative cross-sectional survey method  was used to collect data from the 
subjects. The tool used was questionnaires with predetermined set of questions having a set of 
answer options   on socio-demographic, socio-economic information/level of education, religious 
belief /alcohol history, food and nutrition security, knowledge on antiretroviral therapy (ARV) 
drugs, practice of health care providers and patients on ART, treatment regimen/co-management 
and social-cultural factors, to  access adherence practices. The researcher worked with a 
community counselor at the Oshakati ART clinic. She was responsible for pre and post 
adherence counseling of the patients  before the data collection exercise. 
 
Results: A total of 60 patients were used for the survey. The quantitative data analysis using 
patient self report adherence methods gave the following: Two-weeks recall 98%, 
oneweek78.33% and  four days 68.33%. The mean adherence rates was estimated to be 
88%.Reasons cited for missing medication were unemployment 23%, long waiting time 52%, 
forgetfulness 52%,felt better 20%,too ill/felt worse 15%, side effects and two many pills 3% for 
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TB patients on ART, problem with hospital staff 8%, stock-out 7%,avoiding  friends /relatives 
because of their illness 27%. Alcohol abuse was not reported in this survey as adherence problem 
and was no report of ARV stocks  out from Central Medical Stores during the study(MoHSS, 
2014). 
 
Recommendations:A functional ART committee currently lacking at this unit is recommended. 
Home base care services, follow up print out,community-based approaches, which involves 
training community health workers to supervise ART in patient‟s homes is highly recommended. 
The use of  practical reminders should be communicated to the patients during adherence 
counseling. Furthermore, means of transportation should  be provided for them, like providing  
bus to convey the patients from a central location close to their homes to bring them to the 
hospital and take them back home.   
Conclusions :A lot of efforts is required to improve adherence. The  constraints of adherence 
found in this study should be addressed and more efforts to improve on the strength of the key 
facilitators of adherence. The governments, non government organizations, the commercial 
sector, needs to  work together in a multi-sectoral dimension,  involving the patient, the 
community, health care workers and policymakers in collaboration with  the hospital 
management committees to address  this adherence issues  to make a  big difference. 
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Opsomming 
Namibië is „n klein landjie met „n bevolking van ongeveer 2 miljoen mense. Die gevolge van die 
MIV/Vigs-pandemie is egter vir hierdie land dieselfde as vir enige  ander land. Studies wat in 
Namibië gedoen is dui daarop dat die voorkoms van MIV/Vigs in Namibië baie hoog is, met 
Oshakati die distrik met die hoogste voorkoms in die hele Namibië. 
Die doel van die studie was om te probeer vasstel waarom vroulike MIV-pasiënte nie getrou 
hulle medikasie gebruik nie. „n Verdere doelwit was om riglyne vir die antiretrovirale eenheid 
van die Oshakati hopitaal te ontwikkel ten einde te verseker dat pasiënte hou by die 
voorgeskrewe gebruik van die medikasie wat hulle ontvang. 
Ten einde die navorsing uit te voer is „n vraelys gebruik by „n steekproef van 60 pasiënte  in die 
Oshikati hospitaal in Namibië. Redes wat vir die ongereelde gebruik van medikasie aangevoer is 
was onder andere werkloosheid, lang waglyste by die hospitaal, blote vergeet om medikasie te 
gebruik, pasiënte voel beter en los dan die medikasie, newe-effekte en  alkohol misbruik. 
Voorstelle word aan die einde van die studie gemaak vir die verbetering van die bogenoemde 
situasie. Die daarstelling van „n funksionele antiretovirale komitee word voorsgestel en ander 
praktiese oorwegings ( soos om byvoorbeeld boodskappe aan pasiënte te stuur) word aan die 
hand gedoen. Daar word ook „n sterk motivering uitgemaak vir die beter opleiding vir 
gemeenskapswerkers wat direk met MIV/Vigs pasiënte werk. 
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CHAPTER 1: BACKGROUND AND RESEARCH PROBLEM OVERVIEW 
 
1.1 Background 
Namibia has a small population of about 2 million people and  itsHIV/AIDS situation is not 
different from that of the global trend. Approximately 20% (about 400,000 )of the sexually 
active adult population lives with the virus(MoHSS, 2008). Studies carried out in Namibia in 
2008 shows that 6o% of the female were infected with HIV meaning the other 40% accounted 
for the rest of the population involving  men and children (MoHSS, 2008).  This became a cause 
for concern to stimulate a research in this category of subjects. In Namibia, the national sentinel  
prevalence was 18.8% among HIV pregnant women between  ages 15- 49years. And Oshakati 
was the third highest HIV/AIDS prevalence district in the country with 25.1% and this is higher 
than the national average (MoHSS, 2010:12).This stimulated interest for this study in Oshakati 
district in Namibia.  A non-adherent patient is more likely to ignore caution and thereby more 
likely to contribute to the spread of the disease to the uninfected population. An understanding of 
the reason(s) for non-adherence could lead to measures that would address the issues causing it 
(non-adherence), thereby improving mortality of HIV patients and developing better response to 
counseling, which could in turn, result in the discipline that is needed to curtail the spread of the 
disease in the country. Currently, the reasons for non-adherence are undetermined. Oshakati 
being the largest town in Namibia qualifies it as a reasonable base from which to obtain the 
sample for any research on the national population, including adherence to ART. 
If the spread of HIV is to be successfully stemmed, educational campaigns should be focused on 
the most sexually active section of any population. Of the numerous ways that have be reported 
for contacting HIV, heterosexual sex  seems to top the list. According to Weinstock et al. (2004), 
approximately 18.9 million new cases of STD occurred in 2000 in the United States, of which 
9.1 million (48%) were among persons aged 15-24. Three STDs (human papillomavirus, 
trichomoniasis and chlamydia) accounted for 88% of all new cases of STD among 15-24-year-
olds. A female is needed as a participant in any heterosexual intercourse and it is perhaps 
common knowledge that sexual activity is highest among youths 15-24 years of age (sexual 
desirability being a an asset that goes with youthfulness). All these were taken into consideration 
in the choice of the research interest for this study. 
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1.2 The Namibian situation 
Namibia consists of 13 administrative regions (MoHSS, 2006:8). It has one of the highest HIV 
prevalence rates in the world.  By 2000 approximately 160,000 people aged between 15 and 49 
were infected (MoHSS, 2004). At independence in 1990, life expectancy stood at 60 years. 
According to the 2001 population and Housing Census, the number of death due to HIV/AIDS 
had increased by 80% in the three preceding years. The MoHSS has also estimated that in some 
parts of the country, between 50-70% of hospital admissions were  HIV/AIDS-related (MoHSS, 
2004). But in 2006, only 12 years after independency, life expectancy dropped to 42 years due to 
the spread of HIV/AIDS which was exacerbated by high unemployment rates, poverty and 
violence against women and children (GRN/MoHSS, 2010:12 ).The sentinel surveillance system 
is an initiative that was commenced in 1991 by the World Health Organization (WHO) for 
monitoring influenza diseases. The 2010Sentinel Survey among pregnant women revealed that 
Namibia has a high HIV prevalence rate among adult 15-49 years old, standing at 18.8% and that 
the highest prevalence was observed among women age 30-39 years old – with29.6% in the age 
group of 30-34 years, 29.7% in the age group of 35-39 years, followed by26.4% for the age 
group 40-44 years and the lowest being at 6.6% in the age group of 15-19 years (MoHSS, 2010).   
The national HIV prevalence (derived from a Sentinel Study among pregnant women) for 2010 
was estimated at18.8% (MoHSS, 2010:12).However, the latest overall national HIV prevalence 
of 2012   dropped  to18.2% (MoHSS, 2012). 
 
1.3 The Oshakati District situation 
Oshakati district is situated in the northwestern part of Namibia in Oshana region.  Oshana has a 
population of about 190,000. The Oshakati Intermediate Hospital (also simply referred to as the 
Oshakati Hospital) caters for patients referred from hospitals in the surrounding regions in the 
north (regions like Omusati, Oshikoto and Ohangwena). From the data in the 2001 preliminary 
census, the population of Oshakati was 42,649 individuals – making it the second largest town in 
Namibia after Windhoek (Oshakati is sometimes referred to as a town rather than a district). 
According to the Sentinel Survey in 2006, HIV/AIDS prevalence in Oshakati was found to be at 
27.1% (higher than the national average of 19. 9%). In the Sentinel Survey of 2008, the 
HIV/AIDS prevalence (in Oshakati) dropped to 22.4% (still higher than the national average of 
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17.8%)(MoHSS, 2008).The Sentinel Survey of 2010 rose up to  25.1% and it was still higher 
than the national average of 18.8%. Oshakati has the third highest HIV/AIDS prevalence rate in 
the country (MoHSS, 2010:12).The most recent Sentinel Survey of 2012 gave the figure to be at 
22.0% and it was still higher than the national average of 18.2%. Oshakati became the 7
th
 highest 
HIV/AIDS prevalence rate in the country (MoHSS, 2012). 
 
1.4 Research problem 
At the Oshakati Hospital‟s antiretroviral (ARV)   Clinic, the electronic dispensing tool (EDT) is 
being used for dispensing ARV (drugs) to HIV patients. It is a standard practice that before 
dispensing to the patients already on medications that their pills are counted. During this 
procedure it is regularly observed that a notable number of patients on antiretroviral therapy 
(ART) do not adhere to their treatment regimen. During  the pill counts when the patients 
(including females age between 15-24years) come for follow up, it is often noticed  that their 
medications usually do not balance or add up to what its expected. Some of the patients 
themselves report that they forget to take their ARV medications thereby missing some doses on 
some days, leading to non adherence to their medications. Some of the patients often do not 
volunteer specific reasons why they do not adhere to their medications. The resulting effect is 
that these patients have less than 95% adherence which is less than WHO recommendation of 
greater than 95% adherence in order to achieve maximum therapeutic success (MoHSS, 2010).  
In addition to the above, at the end of April 2011 the  electronic dispensing tool (EDT) recorded 
a number of patients on ARV to be over 16, 000 (including females age between 15-24years). 
This EDT tool stated  that, of this figure, over 15,000 patients had less than 95% adherence 
which is less than WHO recommendation of greater than 95% adherence in order to achieve 
maximum therapeutic success (MoHSS, 2010). This is exactly 93.75% of patients on ARV.These  
figures recorded by this tool could have been  as a result or errors during data capturing or due to 
some other unexplained reasons but this certainly suggests there is a problem with adherence in 
Oshakati district. It is therefore of research importance and interest to determine the cause of this 
poor adherence. 
1.5 Significance of the Research Study 
This study is of  vital importance to determine the level of adherence to ART, and factors 
influencing adherence to highly active antiretroviral therapy (HAART). The findings were to 
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enable the development of interventions  to address the issues of non-adherence among patients 
on ART Oshakati district. The research helps  to provide results to serve as a launching pad for 
further work on adherence and make recommendations to the management of Oshakati hospital, 
policy makers represented in this branch of MoHSS and all other stakeholders for policy 
change(s) if necessary. This research is to  assist in the education and dissemination of 
information to HIV/AIDS patients in order to help them,  adapt their social behavior towards 
improved adherence to ART.  And to develop measures that should prevent psychological and 
emotional apathy to the limited available ARV medication that are  currently available in 
Namibia towards decrease burden of health care expenses associated with failed ART regimen. 
Finally, this  study is to give an indication to serve as an index, of the level of adherence of the 
patients in Oshakati district in Oshana region (as well as other districts of neighboring regions) . 
1.6 Research Question 
The research problem set for this study was to identify the possible factors which could be  
responsible for  poor adherence to ART by young females between the ages of  15-24 years in 
Oshakati district. 
1.7 Aim and Objectives of the Research Study 
1.7.1 Aim 
The aim of the study was to  establish the reason for poor adherence amongst female HIV/AIDS 
patients, 15-24 years of age, that are currently taking their medications from Oshakati hospital‟s 
ARV Clinic in order to recommend good guidelines that will help to improve adherence 
practices. 
1.7.2 Objectives 
The objectives of the study were the following 
 To analyze the current adherence practices being implemented at the Oshakati hospital‟s 
ART Clinic. 
 To identify the reason(s) for the current poor adherence amongst these female- 
HIV/AIDS positive patients (15-24years of age) in Oshakati district. 
 To identify the implementation gapsin the current adherence programs at the Oshakati 
Hospital which are contributing to the current poor level of adherence amongst this group 
of patients. 
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 To make recommendations to the Oshakati Hospital‟s authority to come up with 
guidelines to improve adherence. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction 
This chapter describes  literature review on adherence research work, starting  with the global 
trend  of female HIV/ AIDS  worldwide distribution by the Joint United Nations Program on 
AIDS (UNAIDS)  which was then  followed by the current recommendations, practices and 
monitoring of ART adherence in Namibia. There after a report on  ART adherence research 
works  done  in Tanzania 2005, Botswana 2006, Mozambique (2004-2007) and in some other 
countries of the world. 
2.2 Global trend of HIV/AIDS 
 
Since the HIV/AIDS epidemic began, over 60 million people have been infected with HIV and 
more than 20 million have died of AIDS. Despite wide-ranging interventions to curtail its further 
spread and to mitigate the impact of its effects, there are around 16,000 new infections each day 
and at the crux of the epidemic are young people, accounting for over 50 % of this daily toll 
(Haxthausen and Maluwa 2001: 3). 
 
 Figure 2.1: Percent of adults (15+) living with 
 HIV who are female 1990- 2007 
 
Young people are at the centre of action on HIV/AIDS because silence, taboos and myths often 
surround HIV/AIDS because it is associated with private and intimate behaviors. In this context, 
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many young people are particularly exposed to HIV infection, or vulnerable to needless 
suffering, if they are infected (Haxthausen and Maluwa 2001: 3). 
 
In the world today, HIV/AIDS epidemic has become a serious health problem, by the end of 
2006 the Joint United Nations Program on AIDS (UNAIDS) estimated the number of HIV 
infection to be about 40million, about 24.7million infected people (62% of the total) were in 
Sub-Saharan Africa in 2006 alone, about 4.3million became newly infected with HIV (600,000 
children new infections nearly all of whom were infants born to HIV positive mothers).about 
22million people have died from the disease and most of these came from Africa and  nine  out 
of 10 newly infected infants were in Sub-Saharan Africa (UNAIDS 2006). 
 
The world estimates of HIV infections  was reviewed in 2007 and  estimated to be 33.2million  
out of which 15.4million happened to be women. In many regions of the world more women 
than men are at risk of HIV infection, with 50% of all new daily infections in sub-Saharan Africa 
being in women. Children account for more than 12% of all new infections, and globally 
2.5million children less than 15 years of age were living with HIV in 2007. About 1200 children 
under the age of 15 years become infected with HIV daily (UNAIDS/WHO, 2007). Without 
appropriate care and treatment, more than 50% of newly infected children will die before their 
second birthday. 
 
In 2007, advances in the methodology of estimations of HIV epidemics applied to an expanded 
range of country data that  resulted in substantial changes in estimates of numbers of persons 
living with HIV worldwide. However the qualitative interpretation of the severity and 
implications of the pandemic has altered little. The estimated number of persons living with HIV 
worldwide in 2007 was 33.2 million (30.6-36.1 million),compared with 39.5 million(34.7-47.1 
million)  published in 2006 with  a16%  reduction (UNAIDS/WHO, 2006). The single biggest 
reason for this reduction was the intensive exercise to assess India‟s HIV epidemic, which 
resulted in a major revision of that country‟s estimates. Important revisions of estimates 
elsewhere, particularly in sub-Saharan Africa which  also contributed   to the total difference in 
the estimates published in 2006 and 2007,  seventy  percent were due to changes in six countries 
namely : Angola, India, Kenya, Mozambique, Nigeria, and Zimbabwe. In both Kenya and 
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Zimbabwe, there is increasing evidence that a proportion of the declines is due to a reduction of 
the number of new infections which is in part due to a reduction in risky behaviors. 
It is emphasized that these differences between estimates published in 2006 and those published 
in 2007 resulted largely from refinements in methodology, rather than trends in the pandemic 
itself.  In the following year 2008 global estimates of HIV infections showed slights difference  
in estimates  from about  33.2 million (2007)  to about 33.4million (2008) and to about 33.5 
million  (2010) people living with HIV( of which about 2million are children) about 2.7million 
people with new infections (430,000 where children newly infected) and 2million people died of 
AIDS in that same year and a bout 14million children lost one or both parents in 2008. 
The 2010 report  UNAIDS report on the global AIDS epidemic has got a bold vision of zero new 
infections, zero discrimination and zero aids-related deaths by 2015. Let‟s hope that this 
adherence survey and the interventions recommended would  have contributed its quota towards 
achieving this goal.(UNAIDS 2010:7) 
 
 
Figure 2.2: Adults and children estimated to be living with HIV globally in 2012 
 
2.3 Namibia trend of HIV and AIDS with regards to young people and 
justification for choosing the age group 15-24 years females. 
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In many regions of the world more women than men are at risk of HIV infection (UNAIDS 
2007:7). Namibia situation is not different from that of the global trend. And from studies that 
have been carried out in terms of gender more women than men are infected with HIV in 
Namibia this is a cause for concern to stimulate a research in this category of subjects.In 
Namibia, according to the national sentinel survey prevalence of HIV among pregnant women, 
two sets of age groups were used, age group between  15-24years and between 25- 49years. 
But for the purpose of this study,  the researcher  looked into the first group, the reasons why 
females between 15-24 years of age in Oshakati district are not adhering to their ART treatment. 
The studies that have been carried out in Namibia shows that 6o% accounts for female who have 
been infected with HIV meaning the other 40% accounts for the rest of the population which 
obviously would involve men and children (MoHSS, 2008).The voluntarily counseling and 
testing method used to triangulate the existing ANC HIV prevalence to estimate the general 
population HIV prevalence in Namibia in 2008, 34 232 people were registered as first time 
testers, females were 61% of this total (MoHSS, 2008).And in 2009 the theme  was given 
“Couple HIV Counseling and Testing”  of the  85 635 people which were registered as first time 
testers, 60% were female  accounting for nearly 60% of HIV infections in Namibia (MoHSS, 
2010). In 2011, Katuta stated that in young people that the overall HIV prevalence rate among 
those of high school age 15 to 24 years was 10.3% (Chinsembu, et al. 2011:308). 
 
The situation of the epidemic in the young people of Namibia follows the global trend. It is 
currently estimated that 14% of the general population is infected with HIV according to 
Spectrum estimates of 2009, resulting in about 8,200 AIDS-related deaths every year and 29% of 
all deaths in Namibia. Every day, approximately 32 Namibians are infected with HIV. This 
steady stream of new infections over a long period of time has resulted in an estimated 174,400 
adults and children living with HIV and AIDS in Namibia in 2008. Approximately 248,000 
children 18 years  or younger are orphans and vulnerable children (OVC): about 28% of these 
OVC (69,000) have been orphaned by AIDS according to data from the 2009 Spectrum 
estimates, and Namibia population projections 2001 to 2031 ( Ngartjizeko and  Dan, 2010:9-10). 
Namibia with a generalized HIV/AIDS epidemic, with a national HIV prevalence rate of 18.8% 
in 2010,this is still a very high prevalence when compared to the rest of the world. The apparent 
decrease since 2002 represents the first decrease since the start of ANC surveillance. Since the 
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HIV prevalence is still very high, it means the national response requires continued high levels of 
prevention, care and support services (GRN/MoHSS, 2010).  But in 2008 it was 17.8% among 
those aged 15 to 49 years (GRN/MoHSS, 2008). In 2011, Katuta stated that in young people that 
the overall HIV prevalence rate among those of high school age 15 to 24 years was 10.3%.And 
that HIV prevalence rates were 5.1% in 15 to 19 year olds, 14.0% in 20 to 24 years old and 
23.8% in 25 to 29 year olds (Chinsembu et al. 2011:308-309). Females in Namibia were infected 
quite young, with approximately 10.0% of pregnant adolescents aged 15 to 19 years already 
infected with HIV/AIDS (GRN, 2008). Geographically, HIV prevalence rates are higher in the 
north-eastern part of the country than in the south (GRN, 2008). 
 
 
 
Figure 2.3: HIV Prevalence rate by age Groups and year 
 
In Namibia, the HIV/AIDS epidemic is predominantly due to heterosexual transmission (De la 
Torre et al., 2009). Using secondary data from the Global School Health Survey (GSHS) of 
2004, Chinsembu et al. (2008) reported on the prevalence and social correlates of sexual activity 
among Namibian adolescents  in-school. Although there is co-occurrence of health risk 
behaviors among adolescents, the distribution of specific drivers of the HIV/AIDS epidemic was 
important for designing targeted preventive measures. (Chinsembu et al., 2011:308-309). 
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2.3.1 The trends in the epidemiology of HIV/AIDS in Namibia in terms of age, gender, 
geography & regional distributions. 
The transmission of HIV continues to pose major challenges to Namibia‟s prevention effort. 
Following the first reported aids cases in 1986, data compiled by the ministry of health and 
social services show that AIDS became the leading cause of death in Namibia in 1996.In 1999, 
the reported number of 2,823 AIDS-related deaths accounted for 26% of all deaths and 47% of 
deaths in the age group 15-49 years. The number of reported HIV/AIDS-related hospitalization 
increased more than 20-fold form 355 in 1993 to 7,746 in 2001. 
 
 
 
Figure 2.4: HIV prevalence rate of pregnant women, biannual surveys 1992-2012 in 
Namibia. 
 
The Figure 2.4 above indicates the average HIV prevalence rate overtime. The HIV prevalence 
curve had a precipitous positive gradient from 1992 to 1996 with a moderate increase to 22% in 
2002. This was followed by a moderate decline in 2004 to 19.7% and apparent stabilization to 
19.9% in 2006. The 2008 National HIV Sentinel Survey measured an overall national HIV 
prevalence among pregnant women of 17.8% which represents a clear decrease in  2008 and a 
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slight increase again to 18.8%  in 2010 and a slight decrease 0f  0.6 to 18.2% in 2012 (MoHSS, 
2012). 
 
 
Figure 2.5: Represents the sites with the highest to lowest prevalence in Namibia 
 
Figure 2.5  above  represents regional HIV prevalence distribution in Namibia. Kaitima Mulilo 
has highest prevalence while lowest prevalence  seen in Aranos9%, Rehoboth 6.3% and 
Windhoek Central hospital with 4.7%. 
More than a quarter of pregnant women attending ANC in Katima Mulilo, Okahao and Tsandi 
during the survey period were HIV positive. The lowest HIV prevalence rate is observed among 
pregnant women attending ANC at Windhoek Central Hospital. The reasons are unclear 
(MoHSS, 2008). 
2.4 Provision of highly active antiretroviral therapy (HAART)in Namibia:  
Namibia started offering ART in 2003  as  part of its commitment to the global targets set by 
UNAIDS and WHO “3 by 5” initiative to provide 3 million people living with HIV/AIDS in low 
and middle income countries with life prolonging Anti Retroviral Treatment (ART) by the end of 
2005.   The implementation of ARV therapy is accompanied by a number of challenges. One of 
these challenges is the issue of adherence. The first seven ART sites were launched between July 
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and October 2003 of the same year. Currently there are 44 health facilities offering ART i.e. all 
34 district hospitals and an additional 10 sub-district facilities (large health centre‟s and clinics). 
As at March 2007, over 41,000 people had even been started on ART, of which 33,591 were 
registered as still being on treatment. 66percent of patients on ART are women and 16 percent 
are children. The national target of reaching 30,000 people on ART by 2008, as originally set by 
Medium Term Plan III, has already been exceeded. Of note is that in 2005 the UNAIDS and 
MoHSS revised the national target to 79,942 (2007/08), 92,466 (2008/09)29. Quality of HAART 
services overall is high. 
 
 Reported outcomes for patients on ART in Namibia indicate that 72 percent of  PLWHA is still 
alive since starting ART, 5 percent has died, 2 percent has defaulted and outcomes are unknown 
in 21 percent of cases. Katutura and Oshakati are the two centre that have the highest rate of 
patients in the category unknown. It is likely that back migration of Angolans in Oshakati and 
temporary laborers in Windhoek contributed to a large number of drop outs. Some of these might 
have reregistered in their home area. The new registration system where patients receive a 
unique number for life should make follow up of such cases easier. Still, real drop out or 
defaulting cannot be ruled out especially in the light of a recent adherence study by IBIS in 
which an important number of patients indicated having difficulties in adhering to treatment 
mainly due to lack of food. Prevalence of drug resistance is not known. During the last ANC 
sentinel surveillance, samples were taken for HIV drug resistance threshold.  To date it is 
estimated that two to three percent of the patients receive a second line regimen. There is no 
information on whether switching regimens is due to treatment failure or side effects. Some 
patients are being started on second line treatment to prevent second line medicines from 
expiring (MoHSS, 2010:69). 
 
2.5 Namibia antiretroviral therapy recommendations, practices and adherence 
monitoring. 
 
Medication adherence may be defined as the extent to which a patient takes a medication in the 
way intended by a healthcare provider or the extent to which a patient‟s behavior (taking 
medication, following a diet, and/or executing lifestyle changes) corresponds with agreed 
recommendations from a healthcare provider (WHO, 2003). 
Stellenbosch University  http://scholar.sun.ac.za
14 
 
2.5.1 Namibia antiretroviral therapy current recommendations(MoHSS, 2010) 
The antiretroviral therapy (ART)  guideline was recently revised to accommodate new evidence 
based WHO standards on HIV/AIDS management, it has been adopted an implemented in 
Namibia to specify the clinical and social criteria that patients should meet before being 
commenced on ART, as well as specifying the operational conditions that centers/health 
facilities should meet before starting the program (MoHSS, 2010:12). 
 
Namibian criteria and psychosocial adherence Factors 
In order to meet these criteria specified in the Namibian guideline adherence counseling and the 
role of counselors cannot be overemphasized. 
Definition of Counselling: Counselling involves developing an interpersonal relationship 
between counsellor and clients/patients by helping them to cope better with situations they are 
facing and any emotional problems they might be faced with. Counsellors give the client/patients 
correct information that will help them to make informed decisions (MoHSS, 2008). To 
maximize adherence a team approach is usually used in Oshakati hospital which involve 
physicians, nurses, pharmacists, counselors, social workers, other health care providers, and 
family/friends of the patient where possible according to the guidelines requirement. Pre-ART 
and on-going adherence counseling sessions are done during treatment usually to monitor 
adherence regularly. During counseling the patients are told the social and clinical criteria they 
must meet before starting HAART.  Namibian guideline recommends that  the social eligibility 
criteria for every patient commencing HAART is that such patient should have lived in a fixed 
address for more than 3months and must have access to a designated treatment centre for follow 
up, not abusing alcohol and without unstable psychiatric disorders, amongst others (MoHSS, 
2010:12). A treatment supporter is also recommended to help patient adhere to treatment. 
Though absence of one should not be a reason to deny patients treatment and that adherence 
assessment should be done at each visit (MoHSS, 2010:13).Also, issues related to commitment 
to lifelong treatment, the importance of having a treatment supporter is particularly necessary 
especially in the introduction of directly observed ARV (DART) with caregivers or family 
members‟ assistance may be considered. Adherence is measured through self-report, pill count, 
coming regularly for appointments, viral load, CD4 count just to mention a few (MoHSS, 
2010:13). 
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The clinical criteria specify that adolescents and adults should start ART when they have: 
WHO Clinical stage 1 or 2:Initiate ART if CD4 ≤500 cells/mm3 
WHO stage IV HIV disease: Initiate ARTirrespective of CD4 cell-count. 
WHO stage III or IV HIV and Active TB Disease,  Pregnant and breastfeeding women  and 
Hepatitis B virus Co-infection:  Initiate ART in all individuals regardless of CD4 cell 
count(MoHSS, 2014:14). 
HIV-serodiscordant couples :Provide ART to all HIV-positive individuals in a sero-discordant 
sexual partnership regardless of CD4 cell count or WHO Clinical Stage (to reduce the risk of 
HIV transmission to the negative partner). 
HIV-positive concordant couples currently intending to conceive a child:Provide ART to 
both partners irrespective of CD4 cell count or WHO clinical stage (MoHSS, 2014:14). 
First Line HAART Regimens in Adults in Namibia 
The preferred 1
st
 line regimen has Tenofovir (TDF) rather than Zidovudine (AZT) due to 
evidence of some limitation of future treatment options with AZT as 1
st
 line and to avoid AZT-
induced anemia. However, for patients on TB treatment, Nevirapine (NVP) cannot be used with 
rifampicin and should be replaced with Efavirenz 
(EFV).The guidelines also recommend that Lamivudine (3TC) should be included and Stavudine 
(D4T) avoided (MoHSS, 2014: 17). 
 TDF + FTC(or 3TC) + EFV (once daily FDC)  
 TDF + 3TC + EFV  
 Alternative first line: AZT+ 3TC + [NVP or EFV] 
 TDF + FTC (or 3TC) + NVP  
 ABC + 3TC + EFV (or NVP)  
 Avoid D4T 
The recommended first line regimen for HAART in the Namibian public sector is as shown 
above. For adults (including adolescents ≥ 10 years old and weigh at least 35 kg), pregnant and 
breastfeeding women, adults with TB disease and adults with HBV co-infection (MoHSS, 
2014:14). 
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Fischl et al., (2000) suggest  that 100% adherence levels achieve even greater benefits than 95% 
which may often be complex in terms of the pill burden, dietary restrictions and dosing 
frequency. Where adherence is sub‐optimal ( Hardon et al., 2006:86). 
Patients‟ adherence to treatment can be said to be the most important determinant for the 
therapeutic success of ART. The level to which the virus is suppressed in the blood (and 
consequently, improved immunologic response) depends on the degree of adherence of the 
patient to the therapy. Paterson et al., 2000 determined the correlation between adherence and 
virologic response to ART (MoHSS, 2007:3). 
 
Table 2.1:The correlation between adherence and virologic response 
 
Adherence To HAART Viral Load (<400 C/Ml) 
> 95% 78% 
90-95% 45% 
80-90% 33% 
70-80% 29% 
<70% 18% 
 
WHO recommends an adherence level of >95% for anti-retroviral therapy effectiveness in order 
to reach the desired  therapeutic goal (MoHSS, 2008). 
 
2.5.2   Non-adherence to prescribed HAART Regimens has Implications 
At the beginning of therapy, the viral load is very high. And Carrieri et al., 2003 states that high 
adherence to ARVs is required at this stage because if an individual misses a few doses at this 
stage, the danger of the development of drug‐resistant organisms is far higher than it would be 
after six months of regular treatment, by which time the person is likely to have a low viral load. 
Paterson et al.,  2000 states that to prevent the development of drug‐resistance, an adherence 
level of at least 95% is required for the duration of therapy and especially in the first six month   
( Richard L and.Catherine :2006:26). 
Adherence is closely associated with improved viral suppression, prevention of resistance, delay 
in disease progression and decreased mortality (Torpey et al., 2008), while non-adherence could 
result in emergence and transmission of drug resistant virus strains in the community. In 
addition, there are serious public-health cost implications as patients are shifted from less costly 
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first line to expensive second line regimens (Torpey et al., 2008: 2). In addition ARVs will no 
longer work and the individual will start to suffer from multiple opportunistic infections. 
 ( Richard L and Catherine :2006:26). 
Secondly, the individual may transmit the drug‐resistant virus to their contacts and when those 
individuals go for treatment they will discover that their virus does not respond to the first‐line 
therapy. Once a person develops resistance to first‐line medicines they will need to be changed 
toa more expensive second‐line ARVs. However, at present these products are substantially more 
expensive than the first‐line ARVs and have a different range of side‐effects. (Laing and 
Hodgkin, 2006:26). 
 
2.5.3 Correlates of adherence 
For the treatment with HAART to be successful, the patient has to consistently adhere to the 
prescribed regimen on a long-term basis. It is therefore required to firstly guarantee a patient‟s 
willingness to comply by assessing the patient's readiness to start and adhere to HAART. 
Secondly, monitor the adherence continuously (Stones, 2002).   
Furthermore, Stones ( 2002) states that in order to assist the patient arrive at a well-informed 
decision, the risks and benefits of treatment should always be discussed with he or she before 
therapy is embarked upon. Evaluation of the patient should be based on the patient‟s stated 
commitment to taking medication. As potential evidence of such a commitment, also examine 
the possibility of adherence to appointments and opportunistic infection (OI) prophylaxis. 
Studies have shown that a significant number of patients still do not keep their follow-up 
appointment at various stages of their treatment despite time spent on counseling new patients, 
physical examination and the emphasis placed on the importance of adherence (Bartholomew, 
2004:15). It is appropriate to advise patients that they must aim for greater than 95 % adherence. 
HIV/AIDS is a chronic disease that requires life-long treatment. According to (Sabate, 2001), 
adherence to long-term therapy is poor, averaging 50% and Chen et al., (2001) has suggested 
that only two-thirds of ARV-naïve patients remain on original treatment one year after being 
started on HAART. Some commentators have argued for caution in delivering ART in resource-
poor setting, citing adherence as an issue. Barriers to ARTs adherence varies from setting to 
setting and some researchers consider adherence as a biosocial and dynamic phenomenon 
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(Castro, 2005:338).  This is a major global concern about the treatment of HIV/AIDS and the 
worldwide success of intervention programs to contain the spread of the disease. Interruption of 
HAART entails important risks, including viral rebound, decrease in number of CD4 + T-
lymphocytes (Deeks, 2001:344).  
Adherence can also be assessed, according to Stones (2002), based on a patient‟s self-report 
when the patient is interviewed or responds to a questionnaire or clinical discussion.  Pills can 
also be counted but it was found that many patients occasionally remove more than one dose at a 
time from the medication container, thus leading to undercounting of these ingested doses. 
 
2.6 A report on the ARV adherence situation in Tanzania (2005) 
 In 2005 an estimated HIV prevalence of 7% among the adults was found by the (Tanzania 
Commission for AIDS, 2005) in Tanzania. And not until 2005 there was no attempt to document 
the level of adherence to ARV treatment or to identify possible factors contributing to 
sub‐optimal adherence. This study was designed to help fill that gap. The aim was to measure 
adherence and to identify possible factors and operational barriers facilitating or constraining 
adherence to ART among AIDS patients and to suggest possible ways of improving adherence. 
A cross‐sectional study on ARV adherence was conducted in Arusha and Dar es Salaam in June 
and July 2005, involving a total of seven health care facilities in the two regions. A 
multi‐disciplinary team of researchers collected the data from ARV users through exit 
interviews, semi‐structured interviews, adherence measurement, focus group discussion (FGD) 
and key informant interviews. In seeking information from health care staff, the tools used were 
semi‐structured interviews, observation of staff while conducting consultations, and pharmacy 
stock controls  (Irunde, et al. 2005:173). 
 
A total of 207 ARV users were involved in the study, 26 observations were made, 28 staff  
members  were interviewed, eight FGDs and 10 key informant interviews were conducted, and 
six pharmacy stock checks were carried out in health care facilities. The mean age of ARV users 
studied was 43 for males and 37 for females and most of the ARV users studied were females 
(64%). Most male ARV users were either employed in the private sector or self‐employed in a 
small‐scale business, while female ARV users were either not employed or involved in minor 
trade. Of the staff interviewed, most were nurses.  
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In this study, adherence was considered from the perspective of both the ARV user and the 
health worker. From the ARV users‟ perspective (based on two‐day recall, visual analogue and 
the pill count method) the mean level of adherence was 95%, while from the health workers‟ 
perspective it was found to be 88% (range 60%‐100%). The composite measure of adherence 
using 28‐day visual analogue and pill count method was 90%. However, only 21% of ARV users 
interviewed reported achieving the optimal level of adherence (over 95%) as measured by the 
composite adherence rate. 
 
The remaining 79% self‐reported to achieve only moderate adherence (85%‐95% adherence rate) 
and are therefore at risk of treatment failure and the development of drug‐resistant forms of the 
virus. While most patients seemed to be knowledgeable about ART, a few patients were not 
well‐informed about treatment and the consequences of sub‐optimal adherence to ARVs. The 
main ways of providing this information at the health facilities involved in the study included 
leaflets, seminars, adherence counseling, verbal counseling, television and video. 
The standard of counseling was considered to be good in Dar es Salaam but there was less 
satisfaction with the counseling services provided in Arusha. Despite widespread information 
about HIV and AIDS, the idea of bewitchment as the source of HIV was still reflected in the 
perception of some patients. And although most of the 30 ARV users interviewed during 
semi‐structured interviews (93.5%) had disclosed their HIV status, social stigma was said to be 
widespread. Respondents said that PLWHIV were often stigmatized both at home and in the 
workplace (especially in the private sector). The cost of once‐monthly travel to the clinic for 
ARV users was significant, ranging from  200‐30 000 (approximately 20 US cents to US$ 
30.00), while the distance patients had to travel ranged from 1 km to 246 km. Both ARV users 
and key informants said that lack of food was a problem for most ARV users. This was 
exacerbated by a treatment‐related increase in appetite and by the additional demands of needing 
to take some medicines together with food. However, this did not appear to affect treatment 
adherence among the ARV users involved in the study. Of the ARV users who cited lack of food 
as a problem, all maintained that they had persisted in taking their ARVs. Other interviewees 
remained concerned at the potential impact of hunger on adherence to ART. 
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 For example, it was reported that some patients take their medication only once a day, in the 
evening, because that is the time when they have food and that some patients were selling ARVs 
in order to buy food. This implies that food scarcity can be a drawback to adherence. 
The study identified a number of structural problems in the health facilities involved. For 
example, it was found that consultations carried out in some of the public facilities in Arusha 
were not as conducive to confidentiality as consultations in the public facilities in Dar es Salaam. 
Elsewhere, at the private facilities in both Dar es Salaam and Arusha, confidentiality was said to 
be satisfactory. In addition, ARV users reported that they could spend up to 10 hours in the 
health care facility waiting to be attended to during their monthly visits. Despite these obstacles 
to ARV adherence, the overall mean composite adherence rate of 90% in the two areas surveyed  
which was quite an encouraging result. However, more efforts are needed to ensure optimal 
adherence among the large group (79%) of ARV users who are currently taking less than the 
critical 95% of their dosage. The large variation in the results between pill counts and visual 
analogue demands an explanation. Therefore the two measures needed to be validated against 
viral load, as was done by Carrieri et al. in Malawi. ( Irunde .H et al 2005:215)Unfortunately, 
this  validation could not be done against the viral loads and CD4 cell responses since this was 
not in the original plan of the adherence study, due to financial and logistical barriers to frequent 
laboratory monitoring in this setting. However, the combination of different approaches and 
respondents permitted extensive triangulation that gave a comprehensive set of results of the 
overall mean composite adherence rate of 90% in the two areas surveyed.   
 
2.7 A report on the ARV adherence situation in Botswana (2006) 
Antiretroviral therapy has been available through the public sector in Botswana since 2002. But 
there was continuing concern at the level of adherence. Therefore, studies were conducted in 
Botswana by ( Nwokike J, in  2004)  and reported adherence levels of 83% in the public sector 
and 54% (Weiser, et al., 2003) in the private sector – rates below the minimum level of 95% 
required for treatment success and to help delay the emergence of drug‐resistant strains of HIV 
(Kgatlwane, et al., 86). 
 
 Clinical criteria measurements like CD4 count and viral load were not used in this study like the 
adherence study in Mozambique which was more detailed. In this Botswana study only three 
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tools were used to measure adherence: pill counts over one month; one‐month patient self‐report 
with a visual analogue; and two‐day recall using a 24‐hour ʹsun and moon chartʹ. The mean 
adherence rates were 95% for the pill count, 92% for the one month self‐report and 98% for the 
two‐day recall. Using the pill count method it was found that 75% of the ART users achieved the 
optimal adherence levels of over 95%. Sixty per cent of participants reported optimal adherence 
using the visual line one month recall and 96% reported optimal adherence using the two‐day 
recall ( Kgatlwane, et al., 2006:123). 
 
 The ART program was launched initially in four sites in Botswana, two referral hospitals and 
two district hospitals. The program expanded to such an extent that by end‐2004, all 32 district 
and primary hospitals throughout the country were providing ART. By end‐2005, an estimated 
85% of those in need of treatment were reported to be on ART (WHO, 2006). Overall, 
approximately 63% of the ART patients were females and most are aged 30‐40 years. 
(Kgatlwane  et al., 2006:86). 
 
In 2006  the adherence study was carried out with financial support from the World Health 
Organization (WHO) and technical support was provided throughout by the University of 
Amsterdam (Netherlands) supported by  the Botswana Ministry of Health in facilitating the 
study. This was a cross‐sectional study which used both quantitative and qualitative methods to 
investigate the facilitators of and constraints to adherence to ART among adult patients in four 
public health facilities in Botswana. The research questions necessitated the triangulation of 
methods and this procedure was adopted in the study.(Kgatlwane, Joyce, et al., 2006:91) 
The study was conducted in four district hospitals across Botswana which were providing ART. 
 514 participants were used from the four study sites  which comprised of the following: 122 
(24.7%) were from Maun, 128 (24.9%) from Mahalapye, 115 (22.4%) from Molepolole and 
149(29%) from Serowe. P91All adult patients (aged 18 years or above) on ART at the four 
participating facilities who were willing to take part in the study were eligible for inclusion with 
a mean age of 38.3 years (95% confidence interval 37.4 – 39.2).Most of the patients are in the 
age range 20‐40 (60.2%) and 15% were aged over 50years. The sample included more women 
(67.6%) than men (32.4%) consistent with the current pattern of the Botswana statistics on ARV 
enrolment. Almost 35% had secondary school education level and 42% reported not being in any 
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form of employment. Most of the participants (90%) had been on treatment for less than 24 
months, with an average and median of 11 and 9 months respectively. This reflects the nature of 
the expansion of the program (Kgatlwane  J et al., 2006:103). The optimal adherence rates 
(indicative of being adherent at least 95% of the time) using the pharmacy pill count, self‐report 
(visual line) and self‐report (two‐day recall method) were 75%, 60%, and 96% respectively. The 
composite mean adherence was estimated at 77%. (Kgatlwane J et al., 2006:103) 
The study population consisted of policy‐makers, patients on ART (18years and above) at the 
study sites, health workers and members of the local community. Those who had just been 
referred or transferred from another site to the study site were excluded. Qualitative data were 
obtained using observations, semi‐structured interviews, exit interviews and FGDs.(Kgatlwane, 
et al., 2006:98). 
 
At the end of the study some recommendations were made which included the development  of 
practical guidelines for implementing adherence management strategies. These  included 
guidelines for: continuous adherence counseling; bringing treatment closer to home; adoption of 
a family care model approach to ART; use of practical reminders; adherence case management; 
and the use of medication organizers (pill boxes partitioned to display the daily or weekly 
sequence of pills to be taken). In addition, the establishment of a transport voucher scheme was 
to be considered for people who genuinely  could not afford the cost of transport to collect their 
medication. It was also recommended that such interventions should be evaluated to assess their 
effects on adherence (Kgatlwane J. et al., 2006:130). 
2.8 A report on the ARV adherence situation in Mozambique (2004-2007) 
The Ministry of Health in Mozambique conducted a study on “Treatment outcomes of HIV-
infected Adults Enrolled in the National Antiretroviral Therapy Program –Mozambique, 2004-
2007. It was reported that from 2004-2007 in Mozambique, of the about 290,000 HIV-infected 
adults (>14 years old) needing ART, 85,000 were enrolled in national ART program. Nationally 
representative data on ART program‟s effectiveness has not yet been reported by 2008. 
Retention (the percentage of patients alive and on ART) at 6 and 12 months of follow-up is an 
important measure of ART program effectiveness.  The mean retention in African ART 
programs has been estimated as 79% at 6 months and 75% at 12 months. (Yansaneh, et al., 2009: 
164). 
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The study carried out in Mozambique was a retrospective cohort to assess retention and other 
treatment outcomes among a nationally representative sample of adult patients that were 
initiating ART during the period 2004-2007. Of the 94 ART sites with >50 adults receiving 
therapy, 30 were selected by probability-proportionate-to-size sampling; 2,596 medical records 
at these sites were randomly selected for data abstraction. After controlling for the survey design, 
baseline characteristics, retention, factors affecting retention and improvements in patient health 
status were determined. 
 
The results of the study indicate that at ART initiation, the median age was 34 years, 62% of 
patients were female and many patients had advanced stage of the disease. 66% had a CD4 cell-
count <200/ul and 33% had a viral load (VL) >100,000. Initial ART regimens included 
Stavudine, lamivudine, and Nevirapine or Efivarenz for 88% of patients. Of patients eligible for 
Cotrimxazole (CTX), 33% were documented with CTX prescription at baseline. After 6 and 12 
months of follow-up, retention were 86% and 79% respectively; lost to follow-up (LTFU) were 
10% and 15% respectively, those who died as a result were 4% and 5% respectively, and those 
that stopped ART were 0% and 1%  respectively (Yansaneh, et al, 2009: 164). Table 2.2 below 
gives the retrospective cohort study result in Mozambique to assess retention and other treatment 
outcomes  after 6 and 12 months. 
 
Table 2.2: Retrospective cohort study* to assess 
retention and other treatment outcomes 
 
 
Patients 
Months of follow-up 
6 months 12 months 
Retention (%) 86 79 
Lost to follow-up (LTFU, %) 10 15 
Died as a result (%) 4 5 
Stopped ART (%) 0 1 
*Retrospective cohort study result in Mozambique to assess retention 
and other treatment outcomes  after 6 and 12 months. 
 
For patients with follow-up data, median CD4  cell-counts increased by 147/uL at 6 months and 
174uL at 12 months while median weight gains were 2.2kg at 6 months and 3.4kg at 12 months. 
Viral Load (VL) suppression (VL <1,000 copies/mL) was achieved in 76% and 71% at 6 and 12 
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months respectively (Yansaneh, et al.,  2009: 164) as illustrated in the Table 2.3 below from a 
study in conducted in Mozambique. 
Table 2.3: Study* showing CD4  cell-counts, 
weight gain, and viral load (VL) suppression 
 
 
Patients with follow-up data 
Months of follow-up 
6 months 12 months 
Increase in CD4  cell-counts 147/uL 174uL 
Median weight gain 2.2kg 3.4kg 
Viral Load (VL) suppression (VL <1,000 copies/mL) 76% 71% 
*Retrospective cohort study in Mozambique showing CD4 cell-counts, 
weight gain, and viral load (VL) suppression after 6 and 12 months. 
 
However, there was a higher loss to follow up and low on-time appointments and ARV drug 
pick-up, and 50% of sites reported stock-outs.  To minimize risks, procedures should be put in 
place to increase patient adherence to appointments and ARV pick-up schedules and to prevent 
drug supply stock-outs (Yansaneh, et al., 2009: 109). 
2.8 A report on ART adherence situations in some other countries of the world (2006) 
Percentage of adherence to ART in resource-limited settings in some countries of the world by 
the year 2006 are given below. 
Uganda: 88%, Cote d‟Ivoire: 75%, Haiti: 88%, Senegal: 78%-88%,South Africa: 89%, Brazil: 
range: 57%-87%, Botswana: ~55%, Nigeria: 58%, Kenya: 59% while adherence in some 
resource richer areas are given as follows: Percentage of patients with treatment failure in 
clinical practice reflect a combination of non adherence and resistance as seen in USA: 50%, 
Amsterdam: 40%. (Harvey, M., 2006:12). 
 
Adherence is as problematic in resource-limited settings as it is in resource-rich settings. No 
evidence to show which is more problematic (Harvey, M. 2006:12). It is good to note that there 
is no documentation of overall national adherence for Namibia till date because no national 
adherence survey has been carried out by the Ministry of Health and Social Services. 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
25 
 
CHAPTER 3: RESEARCH DESIGN AND METHODS 
3.1 The research design 
A descriptive research technique involving questionnaires was  used to gather data on a given 
state of affairs in a representative sample of the population (Christensen, 1995:27). In this case, 
the researcher used quantitative method to find out the reason(s) for non-adherence to ART by 
female patients within the age group of 15-24 years from Oshakati District. Questionnaires was 
administered to 60 participants, that entailed the collection of patients‟ answers to a 
predetermined set of indicative questions. To make the implementation easy for the patients, a 
set of answer options  were provided for most of the questions and in some  other cases, the 
questions require short and direct answers that require the sampled patients to provide written 
information about their drugs, habits or issues that affect their adherence practices. The 
researcher  worked with a community counselor based at the Oshakati ART clinic who was 
responsible for pre and post adherence counseling which was done each day with the patients  for 
the survey before the data collection begins to help put the patients at easy. 
 
 
   Figure 3.1: Showing the study site. 
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3.2   The study site  and population 
The study site was the ART Clinic at the Oshakati State Hospital, situated within the Oshakati 
District. The study population consisted of 60female patients who were 15-24 years old and have 
been enrolled on the ART program in Oshakati ART Clinic within the hospital. Two other 
criteria were used to further streamline the sample group for the research and they are considered 
as follows. 
3.3 The inclusion criteria 
HIV/AIDS patients females between 15-24 years old that are enrolled in the ART program and 
on treatment from at least six months prior to the data collection period  were included in the 
study. Patients in this category who gave   their informed consents and theirparents consent  for 
those  less than 18 years and attending the Oshakati Hospital ART Clinic were  also included in 
the survey. 
3.4 The Exclusion criteria 
The patients who were below or above the age group of 15-24years,  not on ART, and were 
unable/unwilling to give informed consent  were excluded. Those  patients who were 
unconscious or mentally unstable (the patients that have been declared by the medical doctors 
treating them  to be mentally unstable and it has been written on the patient prescription and on 
their files, such patients were  not  used)  or those that have enrolled in the ART program for less 
than 6 months and the  patients who could  not speak or understand English consent  were also 
excluded  from this study. 
3.5    Data collection methods 
In this study a cross-sectional survey using quantitative method  was used to collect data. 
A  systematic random sampling was done which involved  sampling of every third patient that 
attended the facility on the day of the field work. Patients who did not want to participate, the 
next patient inline was selected. The data for the study were collected by means of structured 
questionnaires consisting of closed-ended and some open-ended questions. The themes  covered  
were on Socio-demographic, socio-economic information/level of education, religious belief 
/alcohol history, food and nutrition security, knowledge on antiretroviral therapy (ARV) drugs, 
practice of health care providers from patients view, treatment regimen and co-management 
related themes. 
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3.6 Population and sampling 
The sample sizes was calculated to allow detection of a 10% difference in adherence assuming 
adherence is 80% at baseline and 90% at follow-up. The calculation used was  based on a 95% 
level of significance ( 05.0error ) and a power of 80% ( 80.0error ). 3-5 female patients (15-
24 years of age) were interviewed from Monday to Friday on daily basis from April 2012to Mid-
May 2012 until the researcher got 60 patients. 
3.7 Ethical considerations 
All data collected and the survey tools were handled with strict confidentiality.  Access to the 
documents including the information in the computer was restricted  researcher. Informed 
consent was obtained from all the study participants and parents of the participants less than 18 
years. All study participants were  treated in a humane and dignified manner. Their right to 
refuse to participate in the study was highly  respected and had no effect on their continued 
treatment, care and support in the ART program. Participants were  requested to answer a 
questionnaire without names and information provided in the questionnaire was handled 
confidentially. Approval for the research to take place with the patients from the Oshakati 
hospital and the use of hospital equipment was  sought and obtained from the Research Unit of 
the Ministry of Health and Social Services. And permission to conduct the study was also 
obtained from the management of the Hospitals to which Oshakati hospital belongs. Finally  
approval/ ethics clearance was obtained from  the research  committee of the University of 
Stellenbosch before the research was conducted.  
3.8 Data analysis 
The data from the administered questionnaires were initially stored in an Access database 
(Microsoft Access, 2007), utilizing the coding approach. The statistics were generated using Epi 
Info 7.1.2 which was transcribed into statistics-ready forms for analysis. The outputs of the 
analysis will include percentages, figures, graph, bio-graphs and chart which will then be 
subjected to statistical interpretation (Brink, 1999: 61). The analysis will also include tests of 
various statistical hypotheses. 
Statistical Hypotheses 
Include the following below. 
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(i) Non-adherence to ART amongst members of the study sample is correlated to a patient‟s 
inability to provide food for themselves 
(ii) Adherence to ART treatment is higher with disease progression  
(iii) Age is not significant in non-adherence to ART treatment 
(iv) Religion is not a significant factor to non-adherence with ARV treatment, and etc. 
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CHAPTER 4: RESULTS :QUANTITATIVE METHOD PRESENTATION AND 
DISCUSSION OF FINDINGS  
 
To consider  the results and outcome of the tests and analysis that was carried out on the data. 
The emic perspective  will be used because “it assumes that ʹthere is no one correct viewʹ. This is 
a helpful premise when considering the thoughts and opinions of ARV users, health care workers 
and the community, first differently and then collectively. This approach permits a nuanced 
interpretation of what has been reported by a wide variety of respondents.” (Kgatlwane J. et al., 
2006:101).  
4.1 Socio Demographic Characteristics Of Respondents (Includes Age, Religion And 
Education) 
Socio-Demographic Information’s 
Age: The least age was 15years and the oldest was 24years. The mean age was 18.4years as  
shown below. 
Table 4.1: Showing Age range for the study 
 
Obs Variance Minimun 25% Median 75% Maximun Mode Mean Std,Dev 
60 9.6599 15 16 17 21.5 24 16 18.3667 3.108 
 
Marital Status: They were all singles unmarried females 
Educational status: They all had a level of education, majority of them were students.  
There were no complete illiterates. 
 
Table 4.2: Showing Educational status 
 
 
Educational Status 
No Of ARV Users 
Reporting This Reason 
 
Percentage 
Some primary education Std 1- 8 26 43 
Completed primary education 26 43 
Completed secondary education 2 3.3 
Post-secondary education 1 1.67 
Others 5 0 
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4.2 Socio-Economic Information Socio Economical Status: Includes Employment  
Status, Food Security Or Poverty Levels 
 
4.2.1 Religious belief /Alcohol history 
Alcohol consumption is a major problem for most youth in Namibia. However amongst the 
females for this survey, none of them were consuming alcohol and all claimed to be  christians 
and they all said that their church did not stop them from taking their medication. So religion is 
not a significant factor to non-adherence to  ARV treatment in this study group. 
Occupation :43 of them were students, 14 of them unemployed, one farmer and one shop 
attendant. 
Table 4.3: Showing Occupations 
 
 
Occupations 
No Of Arv Users 
Reporting This Reason 
 
Percentage 
Student 43 72 
Unemployed 14 23 
Shop attendant 1 1.67 
Farmer 1 1.67 
Others 1 0 
 
4.2.2 Food and Nutrition Security: The participants main sources of food for their household 
were mainly from two sources: namely 55% from household farm/garden, 38.33%  from 
Purchase (market/grocery) and only 6.6%  from Relatives/friends and none from Welfare/NGO 
support. The participants took meals 48.33% two or three times a day only 3.33% took meal 
once a day.  
44.33%  of the participants did not know how much Namibian dollars they usually spent on 
buying food others spent NS10 to NS400 per month.  
 
4.3 Knowledge On Antiretroviral Therapy (Arv) Drugs. 
Antiretroviral therapy (ARV) use:  It is worthy of note  that 80% of the participants said ARV 
drugs are used for reducing progression of HIV. The other 20%  claimed they did not know the 
use.  But 5% of these said for curing HIV, 13.33 % said for pain reduction and only one patient 
said she did not know its use. 98% claimed one use or the other as the knowledge, which in itself 
would help to motivate these people them to take their medicines. I want to believe that these set 
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of participants because of their educational background understood easily during their counseling 
sections on ARV use. 
Duration on treatment: It is worthy of note that 8.33% (5) of the participants said they have 
been on treatment for 6-12 months and 8.33% (5) also said they have been on treatment for  13 – 
24 months. But majority of the participants 83.33% (50) said they have been on treatment for 
more than 24 months. This shows the nature of the expansion of the ART program in Oshakatic 
hospital. 
Table 4.4: Showing Duration on Treatment 
 
Participants Number 0 5 5 50 
Months 0-6 6 – 12 13 – 24 more than 24 
Percentage 0 8.33% 8.33% 83.33% 
 
Antiretroviral therapy information source: Majority of the participants 45%(27)  said they 
knew about antiretroviral therapy from listening to the radio. Follow by family members 
28.33%(17) , only one (1.67%) person said from television, two (3.33%) people said from news 
papers, three( 5%) said from community awareness meetings. The other ten (16.67%) could not 
specifically say their source of information. In other words 83% of the participants has 
information‟s on  ART. 
 
4.4 Practice Of Health Care Providers From The Patients On Art Point Of View. 
Treatment venue: All the participants interviewed started receiving their treatment and were 
still on treatment from Oshakati hospital at the time this survey was conducted. 
 
4.5 Counseling 
Most of the participants  received counseling before they started their treatment, privacy was 
maintained and different cadre of health personnel‟s  attended to them which we could say that 
this a factor to facilitate adherence. Issues relating to side effects, and the importance of  having 
treatment supporter and completing the full course of their treatment were  emphasized. 
 
Counseling sections: It is good to know that 95% (57) said they received counseling before they 
started their treatment. Only 5% (3) said they did not receive counseling. 
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Counseling times: The analysis  results shows 71.67% (43) said they received counseling three 
times before they started their treatment. 11.67% (7) received counseling two times. Apart from 
the 5% (3) that said they did not receive counseling others said they received counseling more 
than three times.  
Counselors : The analysis  results shows 38.33% (23)  said  community counselors attended to 
them at the counseling sessions,33.33%(20)  said  pharmacists, 15%(9)  said  doctors attended to 
them, 5%(3)  said  nurses attended to them at the counseling sessions. The remaining 8.33% (5)  
were not sure who attended to them. 
Table 4.5: Showing category of health workers that 
counseled the patients for the study 
 
 
 
 
Cadre of staff 
No of participants who 
consulted with this 
category of health 
workers 
 
 
 
Percentage 
Community counselors 23 38.33 
Pharmacists 20 33.33 
Doctors 9 15 
Nurses 3 5 
Others 5 8.33 
Total 60 100 
 
Counseling useful: The analysis  results shows 98.33%(59) reported that counseling is useful for 
HIV patients on treatment only one 1.67% (1)  participant was indifferent.  
 
 Privacy during counseling: The analysis  results shows 96.67% (58) said privacy was 
maintained during consultation, one 1.67% (1)  participant said no privacy and only one 1.67% 
(1)  participant was indifferent. 
 
Side effects during counseling: The analysis  results shows 98.33% (59)  said they were told 
about the side effects and interactions of these drug(s)  during counseling sessions, only one 
1.67% (1)  participant was indifferent.  
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General adherence from a yes or no point of view: The analysis  results shows 98.33% (59) 
said they were able to follow their ARV therapy  treatment regimen, only one 1.67% (1)  
participant was honest enough to say she could not follow her prescribed treatment regimen. 
 
Importance of completing the full course: The analysis  results shows 100% (60)  which is the 
whole participants reported they  were all told about the importance of completing the full course 
of treatment during  their different counseling sessions.  
Treatment supporter: The analysis  results shows 91.67% (55)  reported they have treatment 
supporter, out of  these 50% (30)  have  their parents, 10% (6)   grandparents, 5% (3)  each have 
friends, sisters, caregivers as treatment supporter, 16.67%  (10) could not specify  who their 
treatment supporter was. The remaining 8.33% (5) said they did not have. 
 
Table 4.6: Showing Treatment supporter as stated by the participants for the study 
 
 
Treatment 
Supporter 
No Of Arv Users 
Reporting This 
Reason 
% Of Arv Users 
Reporting This 
Reason 
 
Total Number 
Of Participants 
Have A Treatment 
Supporter (Yes) 
 
55 
 
91.67 
 
60 
Said No Treatment 
Supporter (No) 
 
5 
 
8.33 
 
60 
Friend 3 5 60 
Sister 3 5 60 
Caregiver 3 5 60 
Grandparent 6 10 60 
Brother 1 1.67 60 
Colleague 2 3.33 60 
Other 10 16.67 60 
None 2 3.33 60 
Parents 30 50 60 
 
Transportation: The analysis  results shows 76.67% (46) travel  by Public transport, 15% (9)  
by walking, 5% (3)  by family member‟s vehicle, one said by free hike and the other one said by 
own vehicle that they usually get down to the Oshakati  hospital for treatment. Therefore 55 of 
them all had means of transportation, apart from 5 that were living close to the hospital. 
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Distance/ time The analysis  results shows: 48.33% (29) of the participants  takes 1 – 2 hours, 
35% (21)  takes less than one  hour, and 16.67% (10)  takes 2 – 4 hours, you to reach the 
Oshakati  hospital. 
 
Hospital visit frequency: The analysis  results shows 43.33% (26) of the participants visited 
two monthly, 38.33% (23) of  the participants  visited monthly, and 18.33% (11) of the 
participants  visited the hospital three monthly. None of the participants visited weekly or 
fortnightly. 
 
Waiting time : The analysis  results shows 51.67% (31) claimed  they spent  a whole day, 
21.67% (13)  usually spend  half day, 18.33% (11)  usually spend 2 – 4 hours,  3.33% (2)  
claimed to have spent greater than one day, 3.33%  two (2)  claimed to have  spent 1 – 2 hours,  
while only one claimed to have spent less than one hour  in the ART clinic, before given their 
medications to take home. Worthy of note is the fact that more than half of the participants 
claimed they spend their day in the hospital. 
 
Table 4.7: Showing waiting time as stated  by the participants for the study 
 
 
 
Waiting Time 
No Of Arv Users 
Reporting This 
Reason 
% Of Arv Users 
Reporting This 
Reason 
Total Number 
Of 
Participants 
Less Than 1 Hour 1 1.67 60 
1 – 2 Hours 2 3.33 60 
2 – 4 Hours 11 18.33 60 
Half A Day 13 21.67 60 
Whole Day 31 51.67 60 
Greater Than 1 Day 2 3.33 60 
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Figure 4.1: Showing waiting time as stated by the participants for the study 
 
Acceptability of Waiting time: The analysis  results shows 76.67% (46) of the participants 
claimed that this practice was totally unacceptable (not satisfied) to them. The remaining  
23.33% (14) claimed that this practice was acceptable (satisfied) to them, probably the category 
that spent between 1-4 hours and half day. 
 
 
Table 4.8: Showing acceptability of waiting time as stated by the participants for the study. 
 
 
Acceptability Of 
Waiting Time 
No Of Arv 
Users Reporting 
This Reason 
% Of Arv Users 
Reporting This 
Reason 
Total 
Number Of 
Participants 
Yes 14 23.33 60 
No 46 76.67 60 
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Figure 4.2: Showing acceptability of waiting time as state by the participants for the study. 
 
Reason for unacceptability of waiting time: The analysis  results shows 75%(45) of the 
participants claimed that this practice keeps them away from school or work. Only one 1.67%(1) 
participant said discourages her from continuing treatment. The remaining 23.33% (14) 
participant were indifferent. 
 
4.6 Treatment Regimen and Co-management 
 
The participants were found to be on nine different regimen: The analysis  results shows 38.33% 
(23) of  the participants were on (AZT)/ (3TC) /  (NVP)  single dose combination which was 
taken 12 hourly.Three (3) of  the participants were on (D4T)/ (3TC) + (NVP). One (1) was on 
(D4T)/ (3TC) + Efavirenze (EFZ). Eleven(11) of them were found to be on Efavirenze (EFZ) + 
(AZT/3TC) Zidolam. Three (3) of  the participants were on Efavirenze (EFZ) + (TDF/3TC).  
Two (2) of  the participants were on (TDF/3TC) + Lopinavir/Ritonavir. Thirteen (13)  people on 
(NVP) + (TDF/3TC), and four( 4 ) people on 2
nd
 line treatment, which are three (3) on 
ABC+LP/RT+AZT/3TC and  one (1 ) on TDF+LP/RT+AZT/3TC. 
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Treatment Regimen 
No Of Arv Users 
Reporting This 
Reason 
% Of Arv Users 
Reporting This 
Reason 
Total 
Number Of 
Participants 
(AZT)/ (3TC) /  (NVP)  (FDC) 23 38.33 60 
(D4T)/ (3TC) + (NVP). 3 5 60 
(D4T)/ (3TC) + (EFZ).   1 1.67 60 
(EFZ) + (AZT/3TC) 11 18,33 60 
(EFZ) + (TDF/3TC).   3 5 60 
TDF/3TC) + LP/RT 2 3.33 60 
(NVP) + (TDF/3TC).   13 21.7 60 
ABC+LP/RT+AZT/3TC 3 5 60 
TDF+LP/RT+AZT/3TC 1 1.67 60 
 
Figure 4.3: Showing treatment regiment percentage as stated by the participants for the 
study. 
 
Medicine description: The analysis  results shows 91.53% (54) of the participants were able to 
describe their medications. The remaining 8.47% (6) participants were not able to describe their 
medications. 
 
4.7 Adherence Self-Report 
Table 4.9: Showing adherence self-report( recall method ) as stated bythe participants for 
the study. 
 
 
 
Reason 
No Of Arv Users 
Reporting This 
Reason 
% Of Arv Users 
Reporting This 
Reason 
 
Total Number 
Of Participants 
Generally able to follow 
ARV therapy regimen 
 
59 
 
98.33 
 
60 
Able to follow ARV 
therapy regimen 
Two weeks recall(14days) 
 
 
28 
 
 
46.67 
 
 
60 
Able to follow ARV 
therapy regimen 
One  week-recall(7days) 
 
 
47 
 
 
78.33 
 
 
60 
Able to follow ARV 
therapy regimen Four 
days recall(4days) 
 
 
41 
 
 
68.33 
 
 
60 
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Adherence Percentages 
 
 
 
Figure  4.4: Showing adherence percentage  ( recall method ) as stated by  the 
participants for the study. 
 
Table 4.10: Showing missed doses (recall method) as stated by the participants for the 
study. 
 
 
Adherence: Missed Dose of 
ARV Therapy 
No Of ARV Users 
Reporting This 
Reason 
% Of ARV 
Users Reporting 
This Reason 
 
Total Number 
Of Participants 
Two weeks recall (14days) 32 53.33 60 
One  week-recall (7days) 11 18,33 60 
Four days recall (4days) 17 28.33 60 
Not generally  able to follow 
ARV therapy regimen 
 
1 
 
1.67 
 
60 
 
 
Two weeks (14 days) adherence recall: The analysis  results shows 46.67% (28) claimed that 
they took  their ARV medications as they were told to take it. The remaining 53.33% (32)  
participant were not able to take their medications as prescribed. 
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ARV drugs Source: They all claimed they obtained their ARV medications from Government 
Health central, hospitals and clinic which in this case was Oshakati ARV Clinic. 
 
One week (7 days) adherence recall: The analysis  results shows 78.33% (47) claimed that they 
took  their ARV medications as they were told to take it. The remaining 21.66% (13)  participant 
were not able to take their medications as prescribed. 
 
Difficult to remember: The analysis  results shows 64.41% (38) claimed that they sometimes 
find it difficult to remember to take their medicines. While the remaining 35.59%  (22)  
participants did not find it difficult to remember to take their medicines. 
 
Feeling better: The analysis  results shows 80% (48) claimed that even when they felt better. 
They continued taking their medicines. While the remaining 20% (12)  participants  said they 
stopped  taking their medicines when they felt better. 
 
Four 4 days adherence recall: The analysis  results shows 68.33% (41) claimed that they did 
not missed their ARV medications  but instead took it as they were told to take it. The remaining 
31.66% (19)  participant missed their medication doses  and did not adhere to the  prescribed 
regimens. 
 Feeling worse: The analysis  results shows 76.67% (46) claimed that they continued  taking  
their ARV medications as they were told to take it even when they felt worse . Nine  participant 
said they did  not adhere  to their medication regimen when they felt worse. The remaining 
8.34% (5)  participant  were indifferent. 
 
Medications besides anti-retroviral: The analysis  results shows only two of the participants 
claimed to be taking TB-medications in addition to the ARVS, others claimed to be on Pain 
killers. And none were on self medications,  but claimed all medicines were prescribed by their 
doctors. 
 
Stellenbosch University  http://scholar.sun.ac.za
40 
 
Side effects: The analysis  results shows only 3.33% (2)  participants  said they do experience 
problems taking these medicines together with their antiretroviral but they continued with their 
ARVs and one said  she went to report in the clinic. 
 
Additional counseling: The analysis  results shows 86.67% (52)  participants said they received 
additional counseling  each time before collecting their  medicines. The remaining 13.33% (8)  
participant 
 
Non-availability of medicines : The analysis  results shows 93.34% (56)  participants  said  they 
have not missed any treatment due to non-availability of medicine in the pharmacy. The 
remaining 6.66% (4)  participant  said they missed treatment only once as a result of non-
availability of medicine. 
 
Problems with the hospital/clinic staff: The analysis  results shows 91.67% (55)  participant  
said  they have not ever encounter problems with the hospital/clinic staff. while the remaining 
8.23% (5)  participant  said  they have ever encounter problems with the hospital/clinic staff but 
they continued with their ARVs. 
 
Clinic appointment: The analysis  results shows 10% (6)  participant  said  they have missed 
clinic appointment, 5% (3)  participant  said  it did not affect their appointment. while the 
remaining 5% (49) Others never encountered any problem with the hospital/clinic staff. 
 
Home visits from the hospital/clinic staff: 93.34%(56)  participant  said  they did not receive 
home visits from the hospital/clinic staff, The remaining 6.66% (4)  participant  said they did 
receive home visits from the hospital/clinic staff and out of these four only two responded that 
they were visited twice. 
 
Government of Namibia housing  scheme : The analysis  results shows 96.67%(58)  
participant  agreed that if government of Namibia or NGOS provides them with a housing that it 
will encourage them to take their ARV medications and make them adhere better to their 
treatment regimen. The remaining 3.33% (2) were indifferent. 
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Home-based caregiver :There is no home-based caregiver  services by Oshakatic hospital. But 
some of the participants said they  were visited by other community health workers. Ranging 
from once to greater than three times. 
 
Cost for ARV treatment: The facility does not receive payment for ARV treatment, these were 
confirmed by 58 participants only 2 said they paid for other services in that same clinic. Since 
the facility does not receive payment for ARV treatment, they all confirmed that this had no 
effect on them as regarding their treatments. 
 
4.8 Social-Cultural Factors 
 
4.8.1 Attitude/ perceptions towards ART 
They all approved  use of ART therapy. 
 
Stigma: The analysis  results shows 66.67% (40)  participants  agreed that they do not avoid 
friends or relatives because of their illness, 26.67% (16)  participants  agreed that they do avoid 
friends or relatives because of their illness while the remaining 6.66% (4)  participants were 
indifferent. 
 
Treatment support: The analysis  results shows 83.33%(50)  participants  agreed that in the last 
one month that they had some Immediate member of their family, nurses or community members 
who supported, reminded or encouraged, them to take their ARV medications. 11.67%(7)  
participants  did not receive any kind of support or encouragement. 
 
Positive effect: The analysis  results shows 95% (57) participants agreed that ARV have a 
positive effect on their health. Like gaining more weight/energy gain, no more frequent sickness 
and now growing normally. 
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Table  4.11: Showing summary of the result analysis for the study. 
 
 
 
Reason 
No Of Arv 
Users Reporting 
This Reason 
% Of Arv Users 
Reporting This 
Reason 
 
Total Number 
Of Participants 
Alcohol 0 0 60 
Forgot to take ART 31 51.67 60 
Felt better& stopped ARV 12 20 60 
Too ill/Felt worse 9 15 60 
Stock was finished 0 0 60 
Too many pills/ pill burden 2 3.33 60 
Side Effects 2 3.33 60 
Stock-out 4 6.66 60 
Problem with Hospital staff 5 8.23 60 
Received home-based care 0 0 60 
Payment for ARV treatment 0 0 60 
Avoid friends /relatives because 
of their illness/stigma 
 
16 
 
26.67 
 
60 
Received treatment support in 
the last one month from(family, 
nurses or community) 
 
 
50 
 
 
83.33 
 
 
60 
ARV have a positive effect on 
their health(weight  gain, no  
frequent sickness, normal 
growth) 
 
 
 
57 
 
 
 
95 
 
 
 
60 
Want house from government of 
Namibia or NGOS 
 
58 
 
96.67 
 
60 
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CHAPTER 5: DISCUSSION OF FINDINGS, CONCLUSIONS AND 
RECOMMENDATIONS 
 
5.1 Discussion of Findings 
Based on the results from the research, the researcher used statistical theories to infer 
conclusions about question as to the cause for the poor adherence to ART by young females (15-
24 years) in the Oshakati district.  
Medication adherence was defined as the extent to which a patient takes a medication in the way 
intended by a healthcare provider. And if  a patient did not  take its  medication in the way 
intended then  that is failure to adhere ( poor adherence).  
In this study, 60 people actually participated in this survey. WHO recommends an adherence 
level of >95% for anti-retroviral therapy effectiveness in order to reach the therapeutic goal, 
(MoHSS, 2008).In the measurement of adherence  above four  methods were used  namely: 
General method of a simple yes or no which gave a  98% adherence, two weeks recall (14 days) 
gave a 47% adherence, one week recall (7days) which gave a  78% adherence and , four   days 
recall (4days)which gave a  68% adherence. Average of these methods gave 88% adherence, 
which is less than 95%. But this adherence is similar to that of other studies found in some other 
part of the world ( Kgatlwane J. et al., 2006:124). Most of them (97%) also claimed that if they 
got  free housing from government of Namibia or NGOS that it will help them to adhere better to 
their treatment. 
 
The reasons cited from the study to be responsible of these poor adherence: Reasons cited 
were unemployment 23%, long waiting time (52%) forgetfulness 52%, felt better 20%, too 
ill/felt worse 15%, side effects and too many pills 3%, problem with hospital staff  8%, stock-out 
7%, avoiding  friends /relatives because of their illness 27%. Then 85% had to travel down by 
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means of transportation, this is also cited as an adherence problem, because not everyone could 
afford means of transportation. There is no home-based caregiver services by Oshakati hospital. 
Adherence is a variable that changes over the time, when a patient takes the ARVS as prescribed 
the adherence rate increases and when not adherence rate decreases” (Kgatlwane J. et al., 
2006:124). 
 In this study nobody cited alcohol, stock getting finished from the facility, fear of disclosure as a 
reason for non-adherence. Food and nutrition security was also not a problem in this survey 
because most of the participants had food to eat at least two times a day.  It was only one 
participant that said that  most of the times she did not have food to eat and that was the reason 
she missed her medication doses 20 times within two weeks. 
 
5.2 Facilitators of adherence to ART 
Knowledge and information on antiretroviral therapy: knowledge is  power 83% of the 
participants had information‟s on  ART from listening to the radio, family members, television, 
news papers,  and from community awareness meetings in addition to the hospital. This helped 
them to improve their attitude/perceptions towards ART which led to facilitation of adherence 
because they all approved of ART.  
 
Positive effect: Participants agreed that ARV have a positive effect on their health which is self-
efficacy because they believe in ART that it will help improve their situation. While 80% of the 
participants said ARV drugs are used for reducing progression of HIV. Others said they gained 
more weight/energy gain, there were no more frequent sickness and  their growth continued  
normally. The analysis  results shows 91.67% (55) had treatment supporter in the persons of their 
parents, grandparents, friends, sisters, and caregivers. This is a social support which helped to 
facilitate adherence. 
 
Counseling: Most of the participants (98% )received counseling before they started their 
treatment, and they said it was useful to them. Privacy was maintained and different cadre of 
health personnel‟s attended to them which we could say that this is a factor to facilitate 
adherence. Issues relating to side effects, and the importance of  having treatment supporter and 
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completing the full course of their treatment were  emphasized, I guess that is why most of the 
participants did not report side effects. 
 
5.3 Limitations of the study 
 In this study it was only female participants who understood English that were used,  
male were not used in this survey, which is subject to  selection bias.  
 And the adherence measurement tool used was that of self-report, meaning that some of 
the participants could not have been honest during their reporting, which is also subject to 
selection bias. 
 During the field work, there were some days the researcher could not get participants 
within the age group of 15-24 years and so had to come back the following day. Some of 
the patient who did not give informed consent were not used. These set of people could 
have had useful information on adherence.  
 Clinical criteria measurements like CD4 count and viral load were also  not used in this 
study like the adherence study. 
 Adherence to ART treatment is higher with disease progression could not be established 
in this survey. 
 Under the problem statement, the Oshakati Hospital‟s antiretroviral (ARV)   Clinic, the 
electronic dispensing tool (EDT) is being used for dispensing ARV (drugs) to HIV 
patients  recorded, at the end of April 2011 a number of patients on ARV to be over 16, 
000 (including females age between 15-24 years). The EDT tool states that, of this figure, 
over 15,000 patients have less than 95% adherence which is less than WHO 
recommendation of greater than 95% adherence in order to achieve maximum therapeutic 
success (MoHSS, 2010). 15,000 out of 16,000 is exactly 93.75% of patients on ARV and 
that only 2.25% has greater or equal to 95% adherence. Unfortunately this study alone is 
not enough to say whether or not this claim is right because the average adherence rate by 
this study is 88% which is still less than 95%. I hope this will serve as a launching pad for 
further studies on adherence in this facility. 
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5.4 Summary of results 
The researcher concludes with the fact that the research objectives and statistical hypotheses 
were met. Age and religion were found not to be significant factors to non-adherence amongst 
these ARV treatment users in this facility. Inability of the patients to provide food for themselves 
was not significant to non-adherence in this study because a lot of them could  eat at least two 
times daily. 
 
 
5.4.1 Analyses of result of current adherence practices at the ART Clinic 
The researcher found out the following: 
Pills count: It is a standard practice that before dispensing to the patients already on medications 
that their Pills are counted routinely  and entered into  appropriate data capturing tool  which in 
this case is theelectronic dispensing tool (EDT) at the Oshakati hospital‟s ART Clinic. 
and the patient‟s health passport. 
 
Counseling: Medication related counseling and adherence counseling is done pre-HAART and 
at the time of dispensing treatment. 
 
Treatment Supporters: Their role was to remind patient about dosing, obtaining refills, clinic 
follow-up, encourage patient to attend clinic in case of illness or toxicity and directly observe 
some or all their  doses and  they served as point of contact by health care team if patient misses 
follow-up visits. But under the new guidelines, treatment supporters are no longer “required” 
before patients can start HAART, although they are still strongly encouraged (MoHSS, 2014). 
5.4.2 Reasons for current poor adherence 
Reasons cited were unemployment, long waiting time, forgetfulness, felt better, too ill/felt worse, 
side effects and too many pills for the TB patients who were also on ART, problem with hospital 
staff , stock-out , avoiding  friends /relatives because of their illness  and transportation.. 
5.4.3 Identified implementation gaps 
Oshakati hospital‟s ARV clinic is doing well in program implementation. 
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 A functional ART committee comprising of Senior Medical Officer, ART Doctor, Matron, 
Pharmacist/Assistant, Social Worker, ART Nurse, Counsellors, Laboratory and Community 
Based Organizations is currently lacking at this unit (MoHSS, 2014). 
Home base care services is also lacking at this hospital. 
5.5 Recommendations and conclusion 
A comprehensive national adherence study including clinical criteria measurements like CD4 
count and viral load  and pill count needs to be carried in this Oshakati Hospital‟s and in 
Namibia health services as a whole. The researcher would also like to recommend the use of the 
visual analogue scale for routine adherence monitoring. 
 
A functional ART committee: comprising of Senior Medical Officer, ART Doctor, Matron, 
Pharmacist/Assistant, Social Worker, ART Nurse, Counsellors, Laboratory and Community 
Based Organizations is currently lacking at this unit (MoHSS, 2014). 
Home base care services: This program needs to be implemented because it is currently lacking 
at this hospital. 
 
Follow up print out: This should be done on a weekly basis to print out a list of patients who 
missed their appointments so that they can be contacted. 
 
Community-based approaches to HIV treatment: Training community health workers to 
supervise ART in patient‟s homes is highly recommended. 
 
Transportation: It is highly recommended for means of transportation to be provided for them, 
like providing them with bus to convey the patients from a central location close to their homes 
to bring them to the hospital. 
 
Practical reminders: The patients should be encouraged  to use  practical reminders like cell 
phone alarm  And some specific program on radio and television. 
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ADDENDA 
 
A-Informed consent form 
B-Interview protocol guide 
C-University of Stellenbosch Ethics Committee approval form 
D- The questionnaire used. 
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